November 15, 2011 (San Francisco, California) — A new treatment regimen with the low-molecular-weight heparin enoxaparin reduced the incidence of portal vein thrombosis (PVT), leading to fewer events ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback